Demant A/S (CPH:DEMANT)
341.20
+19.80 (6.16%)
Oct 9, 2026, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 71.96 billion as of October 9, 2026. It is the 2,040th most valuable company in the world and the 12th biggest in Denmark. Its market cap has increased by 45.36% in one year.
Market Cap
71.96B
Enterprise Value
90.82B
Revenue
24.63B
Global Rank
Country Rank
#12 Denmark
PE Ratio
29.72
ChartMarket Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 71.96B, an increase of 3,295.96%. That is a compound annual growth rate of 12.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 71.96B | 56.98% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Genmab | 148.61B |
| Coloplast | 95.99B |
| ALK-Abelló | 48.37B |
| H. Lundbeck | 44.36B |
| Ambu A/S | 18.30B |
| Zealand Pharma | 16.99B |
| Bavarian Nordic | 16.90B |